Holistic care, implementation of physical activity and a healthy lifestyle in patients with PMS symptoms
DOI:
https://doi.org/10.12775/JEHS.2023.26.01.006Keywords
physical activity, stimulants lifestyle, premenstrual syndrome(PMS), premenstrual dysphoric disorder (PMDD), symptoms associatedAbstract
Effective control of fertility and new social roles of women caused that the time when a woman experiences cyclical hormonal changes in the menstrual cycle and the possible adverse symptoms associated with it became the period prevailing during the reproductive period of a woman's life.
Premenstrual syndrome (PMS) comprises clinically significant physical and psychological symptoms that occur during the luteal phase of the menstrual cycle and cause significant distress and functional impairment.
A broadly understood change in lifestyle, diet, systematic increase in physical activity, reduction of stimulants, but above all, keeping a diary of observation of alarming symptoms positively affects the improvement of women's well-being, accelerates the diagnosis and start of treatment.
References
MacDonald PC, Dombroski RA, Casey ML. Recurrent secretion of progesterone in large amounts: an endocrine/metabolic disorder unique to young women? Endocrine Rev 1991; 12: 372-401.
Yesildere Saglam H, Orsal O. Effect of exercise on premenstrual symptoms: A systematic review. Complement Ther Med. 2020 Jan;48:102272. [PubMed]
Frey Nascimento A, Gaab J, Kirsch I, Kossowsky J, Meyer A, Locher C. Open-label placebo treatment of women with premenstrual syndrome: study protocol of a randomised controlled trial. BMJ Open. 2020 Feb 17;10(2):e032868. [PMC free article] [PubMed]
Gudipally, P. R., & Sharma, G. K. (2022). Premenstrual syndrome. In StatPearls [Internet]. StatPearls Publishing.
Yonkers KA, O'Brien PM, Eriksson E. Premenstrual syndrome. Lancet. 2008 Apr 5;371(9619):1200-10. doi: 10.1016/S0140-6736(08)60527-9. PMID: 18395582; PMCID: PMC3118460.
Ryu, A., & Kim, T. H. (2015). Premenstrual syndrome: A mini review. Maturitas, 82(4), 436-440.
Freeman, E.W. (2003). Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology, 28, 25-37.
Clayton A.H.J. Symptoms related to the menstrual cycle: diagnosis, prevalence, and treatment. Psychiatr. Pract. 2008; 14 (1): 13-21.
Jahanfar S., Lye M.S., Krishnarajah I.S. The heritability of premenstrual syndrome. Twin Res. Hum. Genet. 2011; 14 (5):433-6.
Huo L., Straub R.E., Roca C., i wsp. Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1 the estrogen receptor alpha gene. Biol. Psychiatry 2007; 62 (8): 925-33
Pakharenko L. Effect of estrogen receptor gene ESR1 polymorphism on development of premenstrual syndrome. Georgian Med. News 2014; 235:37-41.
Dhingra V., Magnay J.L., O'Brien P.M., Chapman G., Fryer A.A., Ismail K.M. Serotonin receptor 1A C(-1019) G polymorphism associated with premenstrual dysphoric disorder. Obstet. Gynecol. 2007; 110(4):788-92
Biggs, W. S., & Demuth, R. H. (2011). Premenstrual syndrome and premenstrual dysphoric disorder. American family physician, 84(8), 918-924.
Dickerson LM, Mazyck PJ, Hunter MH. Premenstrual syndrome. Am Fam Physician. 2003 Apr 15;67(8):1743-52. [PubMed] [Reference list]
American Psychiatric Association. Diagnostic and statistical manual of mental disorders-DSM-IV. 4. Washington DC: American Psychiatric Association; 1994. [Google Scholar] [Ref list].
ACOG. ACOG practice bulletin: premenstrual syndrome. Int J Gynecol Obstet. 2001;73:183–91. [Google Scholar] [Ref list]
Gudipally PR, Sharma GK. Premenstrual Syndrome. [Updated 2022 Jul 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560698/
Rapkin AJ, Edelmuth E, Chang LC, et al. Whole blood serotonin in the premenstrual syndrome. Obstet Gynecol 1987;70:533-537.
Krawczyk W., Rudnicka-Drożak E. (2011). Zespół wytrzymałości przedmiesiączkowej. Medycyna Ogólna i Nauki o Zdrowi, 17(3), 145-147.
Halbreich U, Petty F, Yonkers K, et al. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am J Psychiatry 1996;156:718-720.
Bloch M, Schmidt PJ, Danaceau M,et al. Eff ects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157:924-930.
Mackenzie TB, Wilcox K, Baron H. Lifetime prevalence of psychiatric disorders in women with premenstrual diffi culties. J Aff ect Disord 1986;10:15-19.
Vaghela N, Mishra D, Sheth M, Dani VB. To compare the effects of aerobic exercise and yoga on Premenstrual syndrome. J Educ Health Promot. 2019;8:199. [PMC free article] [PubMed]
Girman A, Lee R, Kligler B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol. 2003 May;188(5 Suppl):S56-65. [PubMed]
Marjoribanks J, Brown J, O'Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013 Jun 07;2013(6):CD001396. [PMC free article] [PubMed]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Bartłomiej Lepczyński, Aleksandra Kułakowska, Agnieszka Siedlak, Philip Kłakowicz, Sebastian Lechowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 551
Number of citations: 0
